FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

8940901000001109: Available (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298801000001112 Available (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298901000001118 Available en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Available Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Meropenem 500mg powder for solution for injection vials (Consilient Health Ltd) 10 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Aciclovir 250mg powder for solution for infusion vials (Consilient Health Ltd) 10 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Folic acid 5mg tablets (Crescent Pharma Ltd) 28 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Clofarabine 20mg/20ml concentrare for solution for infusion vials (Consilient Health Ltd) 1 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Granisetron 1mg tablets (Crescent Pharma Ltd) 10 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Calcium folinate 50mg/5ml solution for injection vials (Consilient Health Ltd) 1 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Calcium folinate 100mg/10ml solution for Injection vials (Consilient Health Ltd) 1 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Calcium folinate 300mg/30ml solution for Injection vials (Consilient Health Ltd) 1 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Aspirin 75mg tablets (Kent Pharma (UK) Ltd) 28 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Methyldopa 250mg tablets (Esteve Pharmaceuticals Ltd) 56 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Methyldopa 500mg tablets (Esteve Pharmaceuticals Ltd) 56 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Nitrazepam 5mg tablets (Esteve Pharmaceuticals Ltd) 28 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Metronidazole 200mg tablets (Esteve Pharmaceuticals Ltd) 21 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Oxytocin 10units/1ml solution for infusion ampoules (Esteve Pharmaceuticals Ltd) 10 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Gonadorelin 100microgram powder for solution for injection vials (Esteve Pharmaceuticals Ltd) 1 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
GlucoRx Torq oral gel (GlucoRx Ltd) 69 gram 3 x 23g tubes VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ovelle aqueous cream (Ovelle Pharmaceuticals) 100 gram VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ovelle aqueous cream (Ovelle Pharmaceuticals) 500 gram VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ovelle emulsifying ointment (Ovelle Pharmaceuticals) 100 gram VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Ovelle emulsifying ointment (Ovelle Pharmaceuticals) 500 gram VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ovelle Petroleum jelly white (Ovelle Pharmaceuticals) 100 gram VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ovelle Petroleum jelly white (Ovelle Pharmaceuticals) 500 gram VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ovelle zinc and castor oil ointment (Ovelle Pharmaceuticals) 100 gram VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ovelle zinc and castor oil ointment (Ovelle Pharmaceuticals) 500 gram VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Olmesartan medoxomil 40mg tablets (Accord Healthcare Ltd) 28 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Bosentan 125mg tablets (Accord Healthcare Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Bosentan 62.5mg tablets (Accord Healthcare Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml concentrate for solution for infusion vials (Accord Healthcare Ltd) 1 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Busulfan 60mg/10ml concentrate for solution for infusion vials (Accord Healthcare Ltd) 8 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Fluoxetine 10mg capsules (Accord Healthcare Ltd) 30 capsule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Midodrine 2.5mg tablets (Accord Healthcare Ltd) 100 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Midodrine 5mg tablets (Accord Healthcare Ltd) 100 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Isosorbide mononitrate 40mg tablets (Medreich Plc) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Paroxetine 10mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ibuprofen 200mg tablets (Medreich Plc) 84 tablet 7 x 12 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets (Medreich Plc) 28 tablet 2 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Prochlorperazine 3mg buccal tablets (Medreich Plc) 50 tablet 5 x 10 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Mirtazapine 45mg orodispersible tablets (Medreich Plc) 30 tablet 2 x 15 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Oxypro 80mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Amoxicillin 250mg/5ml oral suspension sugar free (Medreich Plc) 100 ml VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Phenytoin sodium 250mg/5ml solution for injection ampoules (Consilient Health Ltd) 5 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Amoxicillin 125mg/5ml oral suspension sugar free (Medreich Plc) 100 ml VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Ixyldone 5mg modified-release tablets (Morningside Healthcare Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Atracurium besilate 50mg/5ml solution for injection ampoules (Consilient Health Ltd) 10 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Oxypro 5mg modified-release tablets (Ridge Pharma Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Oxypro 30mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Oxypro 40mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Irinotecan 40mg/2ml concentrate for solution for infusion vials (Accord Healthcare Ltd) 1 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Levetiracetam 500mg/5ml concentrate for solution for infusion vials (Consilient Health Ltd) 10 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Flumazenil 500micrograms/5ml solution for injection ampoules (Consilient Health Ltd) 5 ampoule VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Atosiban 37.5mg/5ml concentrate for solution for infusion vials (Accord Healthcare Ltd) 1 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Metuxtan SR 500mg tablets (Accord Healthcare Ltd) 28 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Oxypro 15mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Irinotecan 100mg/5ml concentrate for solution for infusion vials (Accord Healthcare Ltd) 1 vial VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Oxypro 60mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Metuxtan SR 500mg tablets (Accord Healthcare Ltd) 56 tablet VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Oxypro 20mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator True Available Inferred relationship Existential restriction modifier
Levobunolol 0.5% eye drops 0.4ml unit dose preservative free VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Beclometasone 50micrograms/dose nasal spray VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Tazarotene 0.1% gel VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Propofol 500mg/50ml emulsion for infusion pre-filled syringes VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Pethidine 50mg/5ml solution for injection ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Ketorolac 30mg/1ml solution for injection ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Pancuronium bromide 4mg/2ml solution for injection ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Suxamethonium chloride 100mg/2ml solution for injection ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Foscarnet sodium 6g/250ml solution for infusion bottles VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Potassium chloride 0.3% (potassium 20mmol/500ml) / Glucose 4% / Sodium chloride 0.18% infusion 500ml bags VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Potassium chloride 0.15% (potassium 20mmol/1litre) / Glucose 5% infusion 1litre bags VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
High Purity Factor VIII 500unit powder and solvent for solution for injection vials VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Phenobarbital 30mg/1ml solution for injection ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Gentamicin 80mg/2ml solution for injection vials VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Budesonide 100micrograms/dose / Formoterol 6micrograms/dose dry powder inhaler VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Iron dextran 100mg/2ml solution for injection ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Rasburicase 1.5mg powder and solvent for solution for infusion vials VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Propranolol 5mg/5ml oral solution sugar free VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Bupivacaine 312.5mg/250ml (0.125%) infusion bags VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Co-danthramer 25mg/200mg/5ml oral suspension sugar free VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Insulin soluble porcine 100units/ml solution for injection 10ml vials VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Doxorubicin 200mg/100ml solution for infusion vials VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Midazolam 2mg/2ml solution for injection ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Omeprazole 10mg dispersible gastro-resistant tablets VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Verapamil 240mg modified-release tablets VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Flecainide 150mg/15ml solution for injection ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Isosorbide mononitrate 60mg modified-release capsules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Isosorbide mononitrate 40mg modified-release capsules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Diltiazem 240mg modified-release capsules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Nifedipine 30mg modified-release capsules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Potassium chloride 20% (potassium 27mmol/10ml) solution for infusion 10ml ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Lidocaine 40mg/2ml (2%) solution for injection ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Lidocaine 400mg/20ml (2%) solution for injection vials VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Sodium chloride 0.9% solution for injection 2ml ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Beclometasone 200micrograms/dose dry powder inhaler VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Oxycodone 5mg modified-release tablets VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Mometasone 200micrograms/dose dry powder inhaler VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Oxycodone 10mg/1ml solution for injection ampoules VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Glyceryl trinitrate 15mg/24hours transdermal patches VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Dalteparin sodium 100,000units/4ml solution for injection vials VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Dalteparin sodium 18,000units/0.72ml solution for injection pre-filled syringes VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Insulin glulisine 100units/ml solution for injection 10ml vials VMP non-availability indicator False Available Inferred relationship Existential restriction modifier
Fondaparinux sodium 10mg/0.8ml solution for injection pre-filled syringes VMP non-availability indicator False Available Inferred relationship Existential restriction modifier

Start Previous Page 3604 of 3707 Next End

This concept is not in any reference sets

Back to Start